SuperworthOric Pharmaceuticals shares outstanding ORIC
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 108M
- On a year earlier
- +38.3%
- more shares
Oric Pharmaceuticals had 108M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 38.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 102.6M | +45% |
| FY2024 | 70.7M | +23% |
| FY2023 | 57.5M | +43% |
| FY2022 | 40.1M | +2% |
| FY2021 | 39.4M | +17% |
| FY2020 | 33.6M | +1609% |
| FY2019 | 2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 108M | +38% | |
| Q1 FY26 | 105.5M | +48% | |
| Q4 FY25 | 102.6M | +45% | |
| Q3 FY25 | 99M | +40% | |
| Q2 FY25 | 78.1M | +11% | |
| Q1 FY25 | 71M | +5% | |
| Q4 FY24 | 70.7M | +23% | |
| Q3 FY24 | 70.5M | +23% | |
| Q2 FY24 | 70.3M | +54% | |
| Q1 FY24 | 67.3M | +49% | |
| Q4 FY23 | 57.5M | +43% | |
| Q3 FY23 | 57.4M | +45% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Oric Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.